Janus Henderson Group PLC Takes $23.73 Million Position in Ovid Therapeutics $OVID
MarketBeat
Janus Henderson Group PLC bought a new position in Ovid Therapeutics (NASDAQ:OVID - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 10,714,000 shares of the company's stock, valued at approximately $23,732,000. Janus Henderson
NASDAQ:OVID